Search PubMed⌕ Search

Biomedical subjects

K Esato

Publications and source records attributed to K Esato.

299 records · Page 17Linked to original sources

99mTc-HSA lymphoscintigraphy and leg edema following arterial reconstruction.

Twelve patients with peripheral arterial occlusive disease were evaluated prospectively in an effort to further investigate the etiology of pedal and lower leg edema that occurs following revascularization (e.g., aorto-iliac or femoropopliteal bypass). Serum total protein, albumin, blood urea nitrogen, and creatinine levels were measured (in addition to peripheral venous pressure), and lymphoscintigraphy of the lower leg was performed. These parameters were assessed just prior to surgery, four weeks postoperatively, and again at follow-up. The serum levels obtained four weeks after surgery and on subsequent follow-ups were significantly higher than the preoperative values. Preoperative peripheral venous pressure was not significantly different from that obtained after surgery. There was no correlation between these pressure measurements and the degree of edema (Grades I to IV correspond to increasing degrees of severity). For both the supine and upright positions, lymphoscintigraphic counts in the inguinal region were significantly higher after surgery. However, the relative increase was dependent upon the severity of edema. The postoperative lymphoscintigraphic count in the upright position was 77 +/- 33 CPS in patients with Grades I and II edema (n = 6) and 20.6 +/- 16.2 CPS in patients with Grades III and IV edema (n = 10) (p less than 0.01). Thus, a lesser degree of postoperative pedal and lower leg edema was associated with higher lymphoscintigraphic counts. We conclude that major contributors to the development of lower extremity edema following arterial reconstruction are failed capillary hydrostatic pressure and interrupted lymphatic drainage.

Aged↗

Myocardial tissue blood flow in allotransplanted rat heart with a special reference to acute rejection.

To evaluate the severity of acute rejection of the homologous heart, myocardial tissue blood flow was measured after a heterotopic heart transplantation in rats. The autograft group (Lewis to Lewis) and the allograft group (DA to Lewis) were compared by graft survival time, myocardial tissue blood flow, myocardial water content, and degrees of histologic alterations. Average graft survival times were longer than 100 days in the autograft group and 5.9 +/- 0.4 days in the allograft group. In the autograft group, myocardial tissue blood flows on postoperative days 1 and 5 were 206 +/- 12 and 189 +/- 18 ml/min/100 gm myocardial wet weight in the left ventricle and 205 +/- 11 and 188 +/- 12 ml/min/100 gm myocardial wet weight in the right ventricle, respectively. In the allograft group, myocardial tissue blood flows on postoperative days 1, 3, and 5 were 222 +/- 30, 164 +/- 22, and 141 +/- 49 ml/min/100 gm myocardial wet weight in the left ventricle and 202 +/- 17, 156 +/- 15, and 147 +/- 46 ml/min/100 gm myocardial wet weight in the right ventricle, respectively. Myocardial tissue blood flows in both ventricles showed significant decreases on days 3 and 5 as compared with those on day 1. Myocardial water content did not alter significantly by day 5 in the autograft group, registering 77.9% +/- 0.6% and 78.4% +/- 1.6%. Myocardial water contents in the allograft group increased significantly as rejection progressed.(ABSTRACT TRUNCATED AT 250 WORDS)

Acute Disease↗

Effect of pancreatopeptidase E (elastase) on the suppression of intimal fibrous proliferation after arterial reconstruction in high cholesterol fed rabbits.

The purpose of this study was to investigate the effect of pancreatopeptidase E (Elastase) administration on the healing of anastomosed arteries. A segment of infrarenal aorta was resected and reanastomosed in rabbits. In the control group, rabbits were fed commercial chow (ORC 4). In the cholesterol group, rabbits were fed a diet of 1% cholesterol added to ORC 4. In the Elastase group, rabbits were fed the same diet as the cholesterol group but received intraabdominal injections of Elastase. The rabbits were kept for 4 months and the abdominal aorta was retrieved for examination. All anastomosed aortas were patent. The cholesterol group developed aneurysmal dilatation in one and stenosis of the anastomosed sites due to hypergranulation in the remaining rabbits. Neither aneurysmal nor stenotic changes were detected in the other groups. We concluded that the administration of Elastase suppressed cholesterol induced atherosclerotic changes at the anastomotic sites in these animals.

Anastomosis, Surgical↗

Transcutaneous PO2 response to transient arterial occlusion in peripheral occlusive disease.

Transcutaneous oxygen tension response to transient arterial occlusion (tcPO2T/2) was examined at the medial mid-calf and dorsum of the foot in 20 patients with thromboangiitis obliterans or arteriosclerosis obliterans, and in normal subjects in order to accurately assess the rate of skin oxygenation. Though the mean value of transcutaneous oxygen tension (tcPO2) correlated with the mean value of tcPO2T/2 before and after arterial reconstruction, a discrepancy between the tcPO2 and tcPO2T/2 values was demonstrated in some cases. The tcPO2T/2 values manifested the severity of the peripheral skin oxygenation more clearly than tcPO2 values because changes in the tcPO2T/2 value paralleled improvement in symptoms after arterial reconstruction. It was concluded that the tcPO2T/2 value was useful in grading the severity of disease, in detecting the site of the arterial occlusion and in evaluating changes in symptoms before and after arterial reconstruction.

Adult↗

Methods of suppression of myonephropathic metabolic syndrome.

Acute arterial occlusion of the extremities may result in severe and complex metabolic derangements. In order to investigate therapeutic means of controlling such metabolic derangements, 19 adult mongrel dogs weighing between 7 and 15 kg underwent acute arterial occlusion by cross-clamping the infrarenal aorta. Clamping was released after 48 hours. The experimental animals were divided into three groups: an untreated group, a THAM group, and a perfusion group. Biochemical and electrolyte analyses were measured before and 1 hour after occlusion, and 1, 3, 12, 24, and 48 hours after the release of occlusion. The SGOT, creatinine, CPK, and aldolase levels rose after release of the occlusion and were significantly higher in the untreated group than in the THAM and perfusion groups. Among these enzymatic changes, the CPK level showed the largest increase. The serum potassium levels remained almost at preocclusion levels after release of the occlusion. It was concluded that the intravenous administration of THAM and peripheral washing were effective against untoward metabolic changes occurring in the ischemic extremities.

Animals↗

Late changes in hemostatic parameters following open-heart surgery.

Changes in hemostatic parameters following open-heart surgery with cardiopulmonary bypass were studied in twelve patients for two postoperative weeks. No clinical manifestations of hemostatic abnormalities were found in these patients throughout the study period. The prothrombin time and activated partial thromboplastin time were within normal limits. The platelet counts and fibrinogen levels were depleted on the first postoperative day, followed by a rapid return to above normal levels within 7 days. The fibrinogen/fibrin degradation products (FDP) showed a peak elevation on the first day, followed by a gradual decline. In 92% of the patients, the FDP levels became elevated to more than 10 micrograms/ml. Rate of the increase in FDP level was closely reflected by the amount of postoperative blood loss when the loss exceeded 10 ml/kg of body weight during 48 hours postoperatively. The levels of plasmin inhibitors (alpha 1-antitrypsin and alpha 2-macroglobulin) were also measured. the alpha 1 antitrypsin was elevated during the postoperative period. The alpha 2-macroglobulin showed no significant changes. In summary, the hemostatic changes following open-heart surgery included activation of the fibrinolytic system and depletion of coagulation factors immediately after surgery, followed by hypercoagulability due to a rapid return to above normal levels of coagulation factors and plasmin inhibitors. We consider, however, these changes to be part of the homeostatic response following open-heart surgery.

Adult↗

Experimental replacement of vena cava with expanded polytetrafluoroethylene graft.

Expanded polytetrafluoroethylene (Gore Tex) grafts were used for the replacement of the superior or inferior vena cava in dogs. When examined 2 weeks to 18 months after the replacement, the overall patency rate was 82%. If neither deformation nor narrowing of the graft on examination by cavagram had occurred within 14 days after implantation, the patency of the grafts remained unchanged. Ninety days after implantation, the formation of pseudointima was almost complete. However, since the grafts were not firmly anchored, superficial desquamation in their mid-portion continued for long periods. A composite graft made up of Gore Tex and noncrimped Dacron was studied in order to know the reason why high patency of the Gore Tex graft was obtained. The pseudointima of the Gore Tex graft gradually increased in thickness for 60 min, after which no further increase was observed. The pseudointima in the Dacron graft thickened markedly as time progressed and additional layers of blood cells accumulated on it. Although the ultimate fate of Gore Tex graft has not yet been determined, experimental trials indicate its suitability for patients requiring replacement of the vena cava.

Animals↗

Is the preferential use of polytetrafluoroethylene grafts for below-knee femoropopliteal bypass justified?

The usefulness of polytetrafluoroethylene graft (PTFE) for primary below-knee femoropopliteal bypass was examined. Forty-five primary femoropopliteal bypasses with PTFE were performed in 35 patients during a 7-year period. Patients were divided into two groups: above-knee (A-K group, n = 20) and below-knee (B-K group, n = 25) bypass. Differences in intergroup patient demographics were not significant. The primary patency rate in the A-K group at 3 and 5 years was 83.6% and 50.2%, respectively, and was 76.2% at both 3 and 5 years in the B-K group. These differences were not significant. Cause of graft failure, 3 grafts in the A-K group and 5 grafts in the B-K group, was kinking or thrombus formation associated with intimal hyperplasia at the distal anastomosis. All grafts in the A-K group with more than 10% stenosis in the early postoperative period had more than 50% stenosis in the late postoperative period. On the other hand, the one graft in the B-K group with 25% stenosis in the early postoperative period had 50% stenosis in the late postoperative period. We concluded that the use of PTFE for primary below-knee femoropopliteal artery is reasonable when atherosclerosis in the proximal popliteal artery is slight. However, close follow-up is necessary to detect and treat graft stenosis early.

Aged↗

Effects of thromboxane A2 synthesis inhibitor (OKY-046) on total liver ischemia in rats.

BACKGROUND: The purpose of this study was to determine the effects of OKY-046, a thromboxane A2 (TxA2) synthesis inhibitor, on the hepatic dysfunction produced in rats by liver cell ischemia and reperfusion injury. METHODS: Total warm ischemia of the liver was induced by the Pringle maneuver for a period of 45 minutes. The animals were divided into two groups; the OKY-046 group, and the control group. These were further divided into three subgroups according to the reperfusion time (5, 30, and 60 minutes). OKY-046 was administered via the femoral vein at a rate of 100 micrograms/kg/min, beginning 20 minutes prior to portal and hepatic arterial cross-clamping, continuing to the termination of the experiment. RESULTS: The ratio of thromboxane B2 (TxB2) to 6-keto-prostaglandin F1 alpha (6 keto PGF1 alpha) ratio in the liver tissue was lower in the OKY-046 group compared to the control group. Significant differences in the hydrous volume of the liver and in the mitochondrial score were noted between the OKY-046 and control groups, indicating liver preservation by OKY-046. CONCLUSIONS: The mechanism of this effect is postulated to be inhibition of the synthesis of TxA2 and enhancement of the levels of endogenous prostacyclin (PGI2). The resulting improvement in the TxA2 to PGI2 balance associated with OKY-046 administration may prevent liver damage in this model.

Animals↗

Effect of elastase on primary graft patency after femoralpopliteal arterial bypass for arteriosclerosis obliterans: a randomized, controlled study.

METHODS: Studies were carried out on 104 limbs with femoralpopliteal bypasses for arteriosclerosis obliterans (ASO). They were randomized to a group receiving elastase (10800 EL. U. P.O. per day) with an antiplatelet drug (Elastase group, 58 patients) or a group receiving only the antiplatelet drug (Control group, 46 patients). The follow-up period ranged from 24 to 36 months after operation at 22 institutions across Japan. RESULTS: The cumulative graft patency rate was higher in the Elastase group than the Control group, but the difference lacked statistical significance. When autogenous saphenous veins were used, the cumulative graft patency rate was significantly higher in the Elastase group than the Control group. CONCLUSIONS: The present study suggests that elastase is effective in maintaining graft patency in femoralpopliteal arterial bypass when an autogenous saphenous vein is used as a graft.

Aged↗

Isolated lung perfusion with cisplatin in a rat lung solitary tumor nodule model.

BACKGROUND: The present study was conducted to evaluate the toxicity, pharmacokinetics and anti-tumor potency of isolated lung perfusion (ILP) with cisplatin in a visible lung tumor nodule model in rats. MATERIALS AND METHODS: A solitary tumor nodule was established by the injection of Methylcholanthrene-induced sarcoma cells into the left lung. Thirty rats were randomized to undergo ILP with either 0.1, 0.25, or 0.5 mg/mL cisplatin and buffered hespan (BHE), or with an intravenous injection of 1.0 or 2.5 mg cisplatin. RESULTS: The highest dose of cisplatin tolerated by the rats was 0.1 mg/mL for perfusion. A much higher platinum concentration in the tumor, of 6.67 +/- 1.64 vs. 2.51 +/- 0.60 micrograms/g tissue, but a significantly lower concentration in the serum and kidneys, was achieved by perfusion compared to that achieved by intravenous injection. A significantly lower tumor weight and 20% complete treatment response was achieved in rats given cisplatin than in those given BHE perfusion at 43.9 +/- 11.6 vs. 226.3 +/- 44.6 mg. CONCLUSION: ILP with cisplatin achieved superior results to intravenous injection according to the levels of toxicity and pharmacokinetic analysis, and it was effective against a visible tumor nodule model in rats.

Animals↗